Advaxis Inc. Stock
Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Advaxis Inc. Stock
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Advaxis Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Advaxis Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Advaxis Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Advaxis Inc. | - | - | - | - | - | - | - |
Beximco Pharmaceuticals Ltd. GDR | - | -5.217% | -4.386% | 4.808% | -0.909% | -57.255% | -14.342% |
Cellectar BioSciences Inc. | -4.970% | -2.339% | -6.704% | 138.571% | 46.491% | -76.479% | - |
SELLAS Life Sciences Group Inc | -2.620% | -1.949% | 2.137% | -13.679% | -1.949% | -86.599% | -99.740% |
Comments
Ayala Pharmaceuticals, Inc. (NASDAQ: ADXS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ADXS provided by MarketBeat
Ayala Pharmaceuticals, Inc. (NASDAQ: ADXS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ADXS provided by MarketBeat
Ayala Pharmaceuticals, Inc. (NASDAQ: ADXS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ADXS provided by MarketBeat